Form 4 filed by Pershing Edward
Pershing Edward filed this Form 4 on PROVECTUS BIOPHARMACEUTICALS, INC. with 2 transaction rows and 0 holding rows, accepted by EDGAR 2026-10-05 14:52:24 UTC.
- Accession
- 0001493152-26-045713
- Filer
- CIK 1689739
- Filed
- 2026-10-05
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: PROVECTUS BIOPHARMACEUTICALS, INC. (CIK 315545)
- Pershing Edward director, officer (CEO), 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| 8% Unsecured Convertible Promissory Note derivative | 2026-10-03 | M exercised | - | $0 | D | |
| Series D-1 Convertible Preferred Stock derivative | 2026-10-03 | M exercised | +13,216 | $0 | 2,975,925 | D |